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Abstract
Background: Since 1953, through the cooperation of state and local health departments, the U.S. Centers for
Disease Control and Prevention (CDC) has collected information on incident cases of tuberculosis (TB) disease in
the United States. In 2009, TB case rates declined -11.4%, compared to an average annual -3.8% decline since 2000.
The unexpectedly large decline raised concerns that TB cases may have gone unreported. To address the
unexpected decline, we examined trends from multiple sources on TB treatment initiation, medication sales, and
laboratory and genotyping data on culture-positive TB.
Methods: We analyzed 142,174 incident TB cases reported to the U. S. National Tuberculosis Surveillance System
(NTSS) during January 1, 2000-December 31, 2009; TB control program data from 59 public health reporting areas;
self-reported data from 50 CDC-funded public health laboratories; monthly electronic prescription claims for new
TB therapy prescriptions; and complete genotyping results available for NTSS cases. Accounting for prior trends
using regression and time-series analyses, we calculated the deviation between observed and expected TB cases in
2009 according to patient and clinical characteristics, and assessed at what point in time the deviation occurred.
Results: The overall deviation in TB cases in 2009 was -7.9%, with -994 fewer cases reported than expected (P <
.001). We ruled out evidence of surveillance underreporting since declines were seen in states that used new
software for case reporting in 2009 as well as states that did not, and we found no cases unreported to CDC in
our examination of over 5400 individual line-listed reports in 11 areas. TB cases decreased substantially among
both foreign-born and U.S.-born persons. The unexpected decline began in late 2008 or early 2009, and may have
begun to reverse in late 2009. The decline was greater in terms of case counts among foreign-born than U.S.-born
persons; among the foreign-born, the declines were greatest in terms of percentage deviation from expected
among persons who had been in the United States less than 2 years. Among U.S.-born persons, the declines in
percentage deviation from expected were greatest among homeless persons and substance users. Independent
information systems (NTSS, TB prescription claims, and public health laboratories) reported similar patterns of
declines. Genotyping data did not suggest sudden decreases in recent transmission.
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Conclusions: Our assessments show that the decline in reported TB was not an artifact of changes in surveillance
methods; rather, similar declines were found through multiple data sources. While the steady decline of TB cases
before 2009 suggests ongoing improvement in TB control, we were not able to identify any substantial change in
TB control activities or TB transmission that would account for the abrupt decline in 2009. It is possible that other
multiple causes coincident with economic recession in the United States, including decreased immigration and
delayed access to medical care, could be related to TB declines. Our findings underscore important needs in
addressing health disparities as we move towards TB elimination in the United States.
Background
Based on National Tuberculosis Surveillance System
(NTSS) provisional data in March 2010, the Centers for
Disease Control and Prevention (CDC) observed that
the decline in reported TB case count in the United
States in 2009 was considerably steeper than in recent
years [1]. TB case rates declined -11.4% in 2009 com-
pared to an average annual -3.8% decline since 2000.
Working with internal and external partners, CDC con-
ducted epidemiologic assessments to explore the sub-
stantial and unexpected TB decline. We sought to
determine if the decline in TB was real, or whether the
decline reflected changes in surveillance reporting or
diagnosis. We examined evidence that the decline might
be due to population changes, improved TB control, or
less transmission of TB.
We investigated the extent to which the decline in
reported TB might be the result of recent revisions to
the NTSS. Health departments in the 50 states and
Washington, D.C. electronically report verified cases of
TB to the NTSS according to a standard case definition.
In 2009, the national TB case definition [2] was modi-
fied. Compared with the 1996 version [3], the updated
case definition incorporates newer diagnostic tests.
Updates to the case definition were coordinated with
revisions in the Report of Verified Case of Tuberculosis,
the standardized national data collection instrument
used to report data to CDC [4]. Major changes to soft-
ware systems used to report cases electronically to CDC
occurred in 2009; specifically, reporting changed from
use of a single CDC software, the Tuberculosis Informa-
tion Management System, to a choice of any software
application (including CDC-developed, vendor-devel-
oped, and state-developed systems) that is compliant
with U.S. National Electronic Disease Surveillance Sys-
tem standards. An additional concern was whether the
United States recession from December 2007 through
June 2009 [5] might have led to underreporting of TB
to CDC, for instance, if routine surveillance could not
be conducted due to health department staff reductions.
Declines might reflect fewer patients seeking medical
care, or physicians considering the diagnosis of TB less
often. We also considered the effect of demographic
changes in immigration, and of revised overseas TB
screening requirements for U.S. immigration applicants
that began to be implemented globally in 2007 and may
have increased TB diagnoses and treatment prior to
immigration, leading to fewer TB diagnoses among
immigrants after U.S. entry [6]. Finally, we considered
whether the decline might reflect a decrease in TB
transmission by examining TB genotype clustering,




TB cases were analyzed for the time period January 1,
2000, through December 31, 2009, as reported by the 50
states and Washington, D.C., to the NTSS, with data
updated through August 27, 2010. NTSS data consist of
annual incident cases of TB disease verified according to
laboratory or clinical criteria [2,3], and include the
month of TB diagnosis verification by public health
departments and of TB treatment initiation, patient
demographics (age, self-reported race, ethnicity [Hispa-
nic or non-Hispanic], country of origin, social risk fac-
tors for TB), and clinical information [9]. Date of
symptom onset is not available in the NTSS. Patient
insurance status and socioeconomic status are also not
available. We analyzed data for foreign-born persons by
length of time in the United States and by country of
birth. U.S.- or foreign-born designation followed U.S.
Census definitions [10].
We collaborated with U.S. TB control officials to vali-
date all individual-level TB case reports for 2008 and
2009 at the county, state, and national level for 10 coun-
ties and one large city that together account for one-
quarter of all TB cases in the United States (23% in
2008). These areas also provided sentinel information by
reporting culture-positive cases of Mycobacterium tuber-
culosis in the first quarter of 2010 for comparison with
2008 and 2009. We assessed the findings from a survey
in March 2010 sponsored by the National Tuberculosis
Controllers Association, which solicited potential evi-
dence of changes in surveillance or clinical practice
from TB jurisdictions, and we analyzed self-reported
data as of August 20, 2010 from 50 CDC-funded public
health laboratories (45 states, 3 large cities, Washington
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D.C., and Puerto Rico) to determine the number of sus-
pected TB patients from whom a specimen was sub-
mitted for testing and the percentage that were culture-
positive for M. tuberculosis complex in 2008 and 2009.
To assess trends in TB therapy initiation, we analyzed
monthly claims for new combined prescriptions of iso-
niazid, rifamycins, and pyrazinamide, from January 2004
through March 2010 from CDC BioSense [11], which
receives RelayHealth™ electronic prescription claims for
20,000-30,000 outpatient pharmacies in 50 states and
Washington, D.C.. For clustering, we studied all cases
reported to the NTSS with complete genotyping results
by spoligotyping and 12-locus mycobacterial inter-
spersed repetitive units analysis [12] with TB treatment
start dates January 2007 through December 2009. Cases
were considered clustered if their M. tuberculosis geno-
type exactly matched another case in the same county
in the same year. We calculated clustering percentages
by dividing the number of clustered cases by the total
cases with genotyping results.
Analyses
Using NTSS data, we tabulated TB observed case counts
for 2009 according to patient characteristics. We log-
transformed counts for years 2000 through 2008, and
performed linear regression to calculate expected cases
and 95% prediction intervals (PI) for 2009. We calcu-
lated the difference between expected and observed
2009 cases, and described the percentage deviation as
the difference divided by expected cases, multiplied by
100. We used a Taylor-series approximation to calculate
variance for determining P values, which were evaluated
for hypothesis generation in conjunction with the mag-
nitude of the deviation and prediction interval bounds.
We obtained population denominators from the U.S.
Census Bureau Current Population Survey annual
March supplement [10] and calculated expected TB case
rates and 95% PI using Poisson regression.
To investigate detailed changes over time, monthly
NTSS data for TB treatment start date were used.
Because of the seasonal pattern of the data, we con-
structed autoregressive integrated moving average
(ARIMA) models for time series. We used 2000-2007
data to estimate ARIMA parameters and forecast
expected monthly counts for 2008 and 2009. ARIMA
models were constructed (p,d,q), (p,d,q) 12 to account
for first-order (monthly) and second-order (yearly) com-
ponents for auto-regressive (p), integrated (d), and mov-
ing average (q) parameters respectively; the observed
data and best-fitting model specified as (0,1,1)(0,1,1)12
are shown in Figure 1. We examined differences
between observed and expected cases by P values, where
Figure 1 Observed tuberculosis cases compared to forecast by treatment start date, 2000-2009, United States. Dots indicate observed
monthly tuberculosis case counts. Solid line indicates autoregressive integrated moving average (ARIMA) model for 2000-2007 with forecasting
for 2008-2009. Dotted line indicates 95% confidence interval.
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P < .05 was interpreted as a significant difference. Simi-
larly, we analyzed monthly BioSense TB medication
pharmacy claims using ARIMA models. Since the
ARIMA model forecasted a moving average, the first
data point reflected the second year of available data for
all analyses (2001 for NTSS, 2005 for BioSense). We
used the Akaike information criterion and Schwarz cri-
terion as well as examination of autocorrelation and
residual plots to evaluate goodness of fit and select best
models. Final model fit was assessed using R2 as the
coefficient of determination.
We used chi-square statistics for categorical compari-
sons such as the percentage of patients reported positive
for M. tuberculosis complex by public health labora-
tories in 2008 versus 2009 and the percentages of geno-
type clustering by year. Categorical comparisons,
regression models, and ARIMA analyses were conducted
in SAS (version 9.2; SAS Institute, Cary, NC). We used
monthly ARIMA values to fit Joinpoint linear regression
models, from which we identified changes in time trends
that were significant at P < .05. Joinpoint is a statistical
software for analysis of trends that starts by assuming
no changes in trend, and uses a Monte Carlo permuta-
tion method to determine the number of significant
flexion points, or changes in trend (Joinpoint version
3.3; Joinpoint, Bethesda, MD) [13].
Results
Decline in TB cases in 2009
In 2009, a total of 11,545 TB cases were reported in the
United States. The percentage difference between
observed and expected 2009 cases was -7.9%, with -994
fewer cases reported in 2009 than expected (Table 1).
The deviation from expected case counts was significant
among both U.S.-born (-7.1%) and foreign-born (-11.1%)
individuals, and was greatest among foreign-born per-
sons who had been in the United States < 2 years before
TB diagnosis (-23.5%). Case counts declined -11.6%
among foreign-born persons from countries that had
updated TB screening procedures for immigration by
adding sputum culture for high-risk persons and tuber-
culin skin testing for children [6], compared with -10.7%
among persons from countries not yet implementing the
changes. Of the top 10 countries of origin of foreign-
born TB patients, two countries had significant declines:
Mexico (-14.8%), which updated TB screening proce-
dures for immigration in 2007, and Guatemala (-27.0%),
which has not yet begun to implement updated proce-
dures. Demographic strata with significant declines
included Hispanics, non-Hispanic blacks, and adults
under age 65 (Table 1). TB declines among homeless
persons and injecting drug users were -17.8% and
-29.6% greater than expected; these declines were predo-
minantly among U.S.-born TB patients.
TB diagnostic and laboratory findings
We examined TB diagnostic characteristics to discover
potential impacts of the revised 2009 TB case definition.
Among cases in the NTSS, the majority (77%) in 2009
were verified by positive culture of M. tuberculosis
(Table 1). Among persons aged 15 years and older with
culture-positive pulmonary TB, there was a -14.2%
decline from expected smear-positive cases and an
-18.1% decline in cavitary disease, with similar declines
among the U.S.-born and foreign-born. Unexpected
declines were significant among both HIV-infected and
uninfected persons (Table 1).
CDC-funded laboratories reported receiving clinical
specimens from 103,708 individual patients in 2008 and
97,568 individual patients in 2009, a -5.9% decrease. In
2008, 4,972 (4.8%) patients had cultures positive for M.
tuberculosis complex; this dropped to 4,217 (4.3%) in
2009, a decline of -9.8% in the proportion positive (P <
.001).
Surveillance reporting system and state-level analyses
Declines from expected counts were similar when com-
paring the 11 states that used the legacy electronic
reporting system in 2009 (-6.7%) to the 39 states and
Washington D.C. that used newly introduced software
systems (-8.8%) [Table 1]. Compared to expected case
counts, 31 states and Washington, D.C. had case
declines; six of the 31 state counts were significantly
lower than expected (Florida, Pennsylvania, North Caro-
lina, Minnesota, Maryland, Michigan).
Of TB control program managers from 59 reporting
areas, 55 responded to the National Tuberculosis Con-
trollers Association survey (93%). We received no indi-
cation of changes in TB diagnostic or laboratory
procedures. We examined the association of case count
declines and staff reductions among 29 states reporting
more than 100 cases in 2008. Unexpected declines were
greatest in the states with no staff reductions (-21.2%),
followed by states that lost 1-3 (-13.9%), more than 3
and fewer than 10 (-8.2%), or more than 10 (-6.1%) staff
positions.
In the 10 counties and one city that matched TB case
records across county, state, and national case reports,
we did not find any cases unreported to CDC in 2008
(n = 2,940) or 2009 (n = 2,496). These jurisdictions
reported the total number of culture-positive cases as
443 for the first quarter of 2008, decreasing to 344 cases
for the first quarter of 2009, but for 2010, increasing to
379 cases in the first quarter.
Time trends in TB treatment initiation and pharmacy
sales
ARIMA analyses showed no difference between 2008
and 2001-2007 TB trends (P = .90), but did show
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Table 1 Observed and expected tuberculosis case counts by select demographic and risk factor characteristics for













Total 11545 12539 (12233 - 12853) -994 -7.9 <.001
Country of origin
Foreign-born 6854 7709 (7318 - 8120) -855 -11.1 <.001
U.S.-born 4571 4918 (4661 - 5190) -347 -7.1 .005
Unknown 120 21 (10 - 48) 99 471.4 .020
For foreign-born, length of stay in United States
< 2 years 1432 1872 (1590 - 2204) -440 -23.5 <.001
> = 2 years 4712 5197 (4865 - 5551) -485 -9.3 .001
Unknown 710 684 (599 - 781) 26 3.8 .587
For foreign-born, country of origin
according to implementation of 2007
immigration technical instructions (TI)
TI countries 2993 3384 (3095 - 3699) -391 -11.6 .002
Non-TI countries 3861 4325 (4044 - 4625) -464 -10.7 <.001
Race/ethnicity
Hispanic 3380 3953 (3563 - 4385) -573 -14.5 <.001
Non-Hispanic
American Indian
102 121 (100 - 148) -19 -15.7 .151
Non-Hispanic
Asian
3192 3355 (3093 - 3639) -163 -4.9 .186
Non-Hispanic
Black
2868 3135 (2963 - 3317) -267 -8.5 .002
Non-Hispanic
Native Hawaiian
75 75 (43 - 130) 0 0.0 1.00
Non-Hispanic
White
1829 1954 (1812 - 2108) -125 -6.4 .085
Non-Hispanic
Multiple/Unknown
99 55 (32 - 95) 44 80.0 .080
Age at TB diagnosis in years
0-4 401 464 (405 - 532) -63 -13.6 .040
5-14 245 292 (241 - 352) -47 -16.1 .061
15-24 1274 1494 (1360 - 1641) -220 -14.7 <.001
25-44 3893 4098 (3897 - 4309) -205 -5.0 .048
45-64 3434 3846 (3624 - 4082) -412 -10.7 <.001
65+ 2292 2358 (2240 - 2482) -66 -2.8 .339
Unknown 6 1 (1 - 1) 5 500.0 .041
Disease location
Pulmonary only 7976 8751 (8436 - 9078) -775 -8.9 <.001
Extrapulmonary only 2383 2594 (2465 - 2730) -211 -8.1 .003
Both 1028 1169 (1031 - 1326) -141 -12.1 .026
Unknown 158 27 (3 - 211) 131 485.2 .344
Case verification
Positive culture 8876 9706 (9423 - 9997) -830 -8.6 <.001
Positive NAA† 57 – – –
Positive smear 91 63 (45 - 89) 28 44.4 .084
Clinical case 1630 1426 (1243 - 1637) 204 14.3 .048
Provider diagnosis 891 1364 (1246 - 1492) -473 -34.7 <.001
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significant declines for 2009 compared to 2008 (P = .01),
and for 2009 compared to 2001-2007 (P = .005) [Figure 2].
Joinpoint analyses identified two significant changes: a
decrease in TB cases starting in October 2008 (95% confi-
dence interval [CI], February 2007 to March 2009) and an
increase in August 2009 (95% CI, December 2008 to Sep-
tember 2009) [Figure 3]. Joinpoint analyses of BioSense
TB prescription claims identified a decrease in March
2008 (95% CI, October 2007 to June 2008) and an increase
in June 2009 (95% CI, September 2008 to September 2009)
[Figure 3].
TB time trends and rates among foreign-born and U.S.-
born persons
Stratified ARIMA models indicated that case counts in
2009 were lower than expected among both U.S.-born
(P = .04; Figure 4) and foreign-born (P = .008; Figure 5)
persons. Joinpoint analyses failed to detect a significant
Table 1 Observed and expected tuberculosis case counts by select demographic and risk factor characteristics for Jan-
uary-December 2009, United States (Continued)
Homeless in the year
prior to TB diagnosis
Yes 571 695 (623 - 774) -124 -17.8 <.001
No 10797 11833 (11540 - 12133) -1036 -8.8 <.001
Unknown 177 57 (22 - 147) 120 210.5 .094
Resident of a correctional facility at time of TB
diagnosis
Yes 461 480 (389 - 593) -19 -4.0 .682
No 11041 12055 (11796 - 12319) -1014 -8.4 <.001
Unknown 43 7 (2 - 29) 36 514.3 .189
Excess alcohol use in the year prior to TB
diagnosis
Yes 1382 1528 (1414 - 1652) -146 -9.6 .013
No 9877 10889 (10641 - 11144) -1012 -9.3 <.001
Unknown 286 180 (129 - 251) 106 58.9 .016
Injecting drug use in the year prior to TB
diagnosis
Yes 152 216 (182 - 256) -64 -29.6 <.001
No 11087 12165 (11831 - 12510) -1078 -8.9 <.001
Unknown 306 203 (129 - 320) 103 50.7 .093
Non-injecting drug use in the year prior to TB
diagnosis
Yes 828 922 (829 - 1026) -94 -10.2 .046
No 10391 11438 (11178 - 11703) -1047 -9.2 <.001
Unknown 326 221 (137 - 355) 105 47.5 .122
HIV status at time of TB diagnosis
Positive 706 797 (748 - 849) -91 -11.4 .005
Negative 6337 7621 (7171 - 8100) -1284 -16.8 <.001
Unknown 4502 4347 (4134 - 4572) 155 3.6 .185
Software for TB reporting‡
TIMS 4455 4775 (4552 - 5009) -320 -6.7 .004
Other 7090 7771 (7470 - 8084) -681 -8.8 <.001
*Expected case counts are derived from ratios (i.e., regression slopes on log-transformed observed counts). Because the sum of ratios is not the ratio of the sums,
expected case counts stratified on case characteristics do not sum to overall case counts. All stratified count differences sum to within the 95% prediction
interval (-688 to -1308) for the overall case count difference (-994).
† NAA = nucleic acid amplification test, which was not recorded as a TB case verification criteria until 2009, thus there are no comparable data from which to
calculate expected values. In 2009, clinical cases include TB verified by positive interferon gamma release assay (IGRA) in lieu of tuberculin skin test, or by
abnormal chest computerized tomography (CT) scan in lieu of chest radiograph; previously, such cases were verified by provider diagnosis because the National
Tuberculosis Surveillance System did not collect IGRA or CT scan results prior to 2009.
‡TIMS = Tuberculosis Information Management System in operation since 1998. Other = National Electronic Disease Surveillance System-compliant software
newly introduced in 2009.
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change in monthly trend attributed to a single flexion
point in time among U.S.-born persons, but did find a
significant decrease among foreign-born persons begin-
ning in November 2008 (95% CI, June 2007 to May
2009) [Figure 3]. When data for foreign-born persons
were examined by time since U.S. arrival, a significant
decrease was identified in October 2007 (95% CI, Febru-
ary 2007 to March 2008) among those with less than 2
years between arrival and TB treatment; however, no
significant change point in time was identified for for-
eign-born persons with more than 2 years since arrival.
Values of R2 for the ARIMA models ranged from 0.93
to 0.96, indicating excellent model fit. No outliers were
detected for foreign-born or overall TB cases, with three
moderately outlying points detected for U.S.-born cases.
After adjustment for outliers, the revised R2 for U.S.-
born changed from 0.93 to 0.94.
According to Census data, the population of U.S.-born
persons in the United States increased 1.1% in 2009
compared with 2008; in contrast, the population of for-
eign-born persons fell 1.6% during this time. The rate of
TB in 2009 among U.S.-born persons was 1.7 per
100,000, compared with an expected 1.9 per 100,000
persons (95% PI, 1.8 to 1.9). Among foreign-born per-
sons, the rate of TB in 2009 was 18.7 per 100,000
persons, compared with an expected rate of 19.3 per
100,000 (95% PI, 18.8 to 19.9).
TB transmission analyses
Among foreign-born persons, genotype clustering
decreased during 2007-2008 (26.3% to 23.2%; P < .001)
and 2008-2009 (23.2% to 20.2%; P < .001), while among
the U.S.-born, clustering decreased from 2007-2008
(35.5% to 32.4%; P = .01) but not from 2008-2009
(32.4% to 31.2%; P = .36). Based on published ranges
[14,15], we estimated the probability of transmission
from a foreign-born source case to a U.S.-born second-
ary case as between 0.8% and 4.5%. The decline of -855
foreign-born cases (Table 1) might have resulted in
between -38 to -6 fewer U.S.-born secondary cases.
Discussion
We conclude that observed declines in 2009 TB case
counts accurately reflect a true decline in the number of
TB cases diagnosed in the United States, and that the
deviation from past trends is significant. The unexpected
decline in reported TB cases began rather abruptly in
late 2008 or early 2009, and may have begun to reverse
in mid 2009. We were able to exclude changes in elec-
tronic reporting systems as a causal factor, since
Figure 2 Difference between observed and expected tuberculosis cases by treatment start date, 2000-2009, United States. Solid line
indicates the difference between observed and expected tuberculosis case counts based on autoregressive integrated moving average (ARIMA)
model, dotted line indicates 95% confidence interval.
Winston et al. BMC Public Health 2011, 11:846
http://www.biomedcentral.com/1471-2458/11/846
Page 7 of 12
Figure 3 Tuberculosis trends for all cases and foreign-born cases* (National Tuberculosis Surveillance System) and outpatient
pharmacy claims (BioSense). * U.S.-born cases showed significant decline in 2009 but analyses did not detect significant change attributed to
a single flexion point in time.
Figure 4 Difference between observed and expected U.S.-born tuberculosis cases by treatment start date, 2000-2009, United States.
Solid line indicates the difference between observed and expected tuberculosis case counts based on autoregressive integrated moving average
(ARIMA) model, dotted line indicates 95% confidence interval.
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declines were seen in states that used new software and
well as states that did not. Independent information sys-
tems (NTSS, BioSense prescription claims, and public
health laboratories) reported similar magnitude declines.
Reductions in TB program staff were not associated
with greater declines, and TB controllers reported no
procedural changes. We found no cases unreported to
the NTSS in our examination of over 5400 individual
line-listed reports in 11 areas. A detailed study in two
states similarly found no evidence of surveillance under-
reporting [16].
Declines were seen both in culture-positive TB cases
and in cases lacking diagnostic laboratory findings. Ana-
lyses showed declines particularly among the foreign-
born, and among Hispanics and non-Hispanic blacks.
Declines were observed among foreign-born persons
from countries that implemented new TB procedures
for overseas screening and from countries using older
procedures for pre-immigration screening. Updated pre-
immigration screening to identify and treat TB prior to
U.S. arrival is expected to reduce TB in the United
States. A recent California study reported decreased TB
incidence diagnosed within 6 months of U.S. arrival in
persons screened with revised pre-immigration TB
screening, compared to persons screened under the
older procedures [17]. Authorized immigrants screened
prior to U.S. arrival comprise approximately 500,000
arrivals in the United States each year, compared to
greater than 160 million annual nonimmigrant admis-
sions among students, temporary workers, diplomats,
family members, and visitors, who are not routinely
screened prior to U.S. arrival [18]. Because immigration
status was not available for analysis of NTSS data, we
were not able to adjust for whether foreign-born per-
sons diagnosed with TB in the United States were
screened with the revised or older pre-immigration pro-
cedures, only whether they originated from a country
that had begun to implement updated procedures prior
to 2009.
The unexpected decline in TB cases among the for-
eign-born could have occurred because of fewer persons
entering or more persons leaving the United States. U.S.
Census figures estimate a -1.6% decline in the foreign-
born population from 2008 to 2009. Since there was an
-11.1% decline in observed compared with expected for-
eign-born TB cases, the decline in population does not
explain the entire decline in foreign-born TB case
counts. Our finding that the decline in foreign-born
cases was most prominent among those whose TB
occurred within 2 years of their arrival, and among
Figure 5 Difference between observed and expected foreign-born tuberculosis cases by treatment start date, 2000-2009, United
States. Solid line indicates the difference between observed and expected tuberculosis case counts based on autoregressive integrated moving
average (ARIMA) model, dotted line indicates 95% confidence interval.
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persons from Mexico and Guatemala (who together
comprised 26% of foreign-born cases), might indicate
that the March 2009 Census population data do not
accurately reflect population changes in these groups.
Department of Homeland Security data suggest greater
declines in the foreign-born population in the United
States than do Census data, including a -6.9% decrease
from 11.6 to 10.8 million unauthorized immigrants from
2008 to 2009 [19]. Our finding is consistent with ana-
lyses showing that the decline in unauthorized immi-
grants in the United States is strongly associated with
decreased immigration from, and increased deportation
to, Mexico [20]. Nonimmigrant authorized admissions
to the United States also declined, from 175.4 million in
2008 to 162.6 million in 2009 [18]. Financial data indi-
cate that remittances to Mexico and Latin America
began to decline in 2008 and early 2009, consistent with
the timing of TB declines, and began to rebound in late
2009 [21].
Case count declines among the U.S.-born were less
impressive than among the foreign-born and cannot be
substantially explained by less TB transmission from
fewer foreign-born cases or by less transmission among
the U.S.-born, since genotype clustering among the U.
S.-born did not significantly decline from 2008 to 2009.
A limitation of this analysis is that, although genotype
clustering is thought to be associated with recent trans-
mission, it is not a direct measure of transmission.
Nevertheless, assessment of clustering did not show an
abrupt decline in genotype clustering coincident with
the abrupt decline in TB cases, suggesting that the
decline in cases was not the result of a sudden improve-
ment in TB control practices.
Some of the most dramatic percentage declines
occurred among minorities and the socially disadvan-
taged. These declines may reflect a general problem of
delayed access to diagnostic services related to the
recent economic recession and some combination of
loss of health insurance, fear that seeking medical care
might lead to legal consequences, or inability to pay for
services [22-24]. We were not able to assess health
insurance status or health seeking behavior among TB
patients; however, recent national reports of overall
declines in physician visits [25] and correlation between
unemployment and TB incidence [26] suggest that the
decline in reported TB cases may be further evidence of
the impact of the economic recession.
Our finding that laboratory reports of culture-con-
firmed diagnoses of TB as a proportion of specimens
submitted declined more (-9.8%) than did the number
of patients who had specimens submitted for culture
(-5.9%) is not consistent with a decline in the index of
suspicion for TB among healthcare providers. The
abruptness of the decline in cases beginning in late
2008 or early 2009 is also not consistent with this
hypothesis.
Although we ruled out surveillance artifact in terms of
the total case count, there were increases in missing
data in some routinely collected variables, representing
small numbers but large increases compared to expecta-
tion, which could affect the interpretation of our ana-
lyses. For example, if missing data for social risk factors
such as injecting drug use and homelessness were com-
plete, our finding of steep declines among persons with
these risk factors might either remain unchanged (if
missing responses were “no,” or were distributed pro-
portional to observed data) or be attenuated to indicate
lesser declines (if missing social risk factors were “yes”).
Typically, the national surveillance database becomes
more complete over time, since TB programs have two
years to follow and close out cases in electronic report-
ing. This incompleteness represents a limitation to using
surveillance data for our comparison of observed case
counts to expected counts based on prior year counts,
which are more complete.
In 2010, provisional NTSS data include 11,181 TB
cases reported in the United States, for a rate of 3.6
cases per 100,000 population, which was a decline of
-3.9% from 2009 similar to the average decline in TB
rates (-3.8% per year) from 2000-2008 [27]. Although
the steady decline in TB rates in the United States is
evidence of continued progress in TB control, the
abrupt decline in 2009 followed by a return to average
decline is not consistent with sudden improvements in
TB control efforts. Multiple causes coincident with eco-
nomic recession in the United States, including
decreased immigration and delayed access to medical
care, could be related to TB declines.
Conclusion
While a greater-than-expected decline in a deadly infec-
tious disease is usually reason for celebration, our results
suggest caution. To the extent that the 2009 TB decline
was due to change in immigration patterns, we might
expect future increases as the economy improves and
the immigrant population increases [28-30]. To the
extent that declines represent delays in accessing health
care, there might be a greater than expected number of
future TB diagnoses, and future cases may be more
advanced, more infectious, and more difficult to cure
[31]. Ecologic data suggest that rebounds in infectious
diseases after economic disruption can have long-stand-
ing consequences [32]. To achieve TB elimination in the
United States, public health programs must address con-
ditions associated with TB and with disparities in
obtaining health services [33].
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